FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096526866> ?p ?o ?g. }

• W3096526866 endingPage "51.e3" @default.
• W3096526866 startingPage "42" @default.
• W3096526866 abstract "Biosimilars – biological medicines highly similar to a licensed reference product (RP) – can mitigate the risk of drug shortages by providing treatment alternatives and, with their lower costs, increase patient access to medication and reduce health care expenditure. However, limited knowledge of biosimilar approval processes and lack of confidence in their quality and efficacy can limit their uptake. Importantly, biosimilars are approved based on tightly controlled regulatory pathways to demonstrate that the physical, chemical, and biological properties of the proposed biosimilar are highly similar to the RP, with no clinically meaningful differences. Initially, a battery of highly sensitive in vitro studies are performed, comparing critical quality attributes between the proposed biosimilar and RP. Subsequently, in vivo pharmacodynamic studies compare the activity and physiologic effects of the biosimilar and RP. Finally, clinical studies are conducted, including a pharmacokinetic equivalence study and a confirmatory comparative clinical trial. The latter is performed in the most sensitive patient population for which the RP is licensed, to provide the greatest possibility of identifying any clinically meaningful differences between the proposed biosimilar and RP. When equivalent safety and efficacy have been demonstrated in one setting, the totality of evidence, together with scientific justification that there are no anticipated differences between the RP and proposed biosimilar in mechanism of action, pharmacokinetics, immunogenicity or toxicity, allows extrapolation into indications where clinical studies were not performed with the proposed biosimilar. Here, we review the approval process for biosimilars, focusing on the licensing of bevacizumab biosimilars and their extrapolation to metastatic colorectal cancer." @default.
• W3096526866 created "2020-11-09" @default.
• W3096526866 creator A5003117278 @default.
• W3096526866 creator A5021967161 @default.
• W3096526866 creator A5024180743 @default.
• W3096526866 creator A5052808201 @default.
• W3096526866 creator A5074210261 @default.
• W3096526866 date "2021-03-01" @default.
• W3096526866 modified "2023-10-17" @default.
• W3096526866 title "Clinical and Regulatory Considerations for the Use of Bevacizumab Biosimilars in Metastatic Colorectal Cancer" @default.
• W3096526866 cites W1872884077 @default.
• W3096526866 cites W1960922507 @default.
• W3096526866 cites W1980650956 @default.
• W3096526866 cites W2052230616 @default.
• W3096526866 cites W2066085836 @default.
• W3096526866 cites W2083367111 @default.
• W3096526866 cites W2108923852 @default.
• W3096526866 cites W2115330744 @default.
• W3096526866 cites W2131881867 @default.
• W3096526866 cites W2143743735 @default.
• W3096526866 cites W2145835533 @default.
• W3096526866 cites W2151337547 @default.
• W3096526866 cites W2157769714 @default.
• W3096526866 cites W2171701559 @default.
• W3096526866 cites W2177394793 @default.
• W3096526866 cites W2298790377 @default.
• W3096526866 cites W2334680921 @default.
• W3096526866 cites W2352496782 @default.
• W3096526866 cites W2394780878 @default.
• W3096526866 cites W2574068890 @default.
• W3096526866 cites W2608742892 @default.
• W3096526866 cites W2615381962 @default.
• W3096526866 cites W2732780718 @default.
• W3096526866 cites W2752880203 @default.
• W3096526866 cites W2789661389 @default.
• W3096526866 cites W2793866077 @default.
• W3096526866 cites W2794416238 @default.
• W3096526866 cites W2801271875 @default.
• W3096526866 cites W2883101577 @default.
• W3096526866 cites W2892127387 @default.
• W3096526866 cites W2892214336 @default.
• W3096526866 cites W2893646688 @default.
• W3096526866 cites W2916186321 @default.
• W3096526866 cites W2921716909 @default.
• W3096526866 cites W2922098133 @default.
• W3096526866 cites W2941607706 @default.
• W3096526866 cites W2950336427 @default.
• W3096526866 cites W2963334060 @default.
• W3096526866 cites W2976821135 @default.
• W3096526866 cites W2978562815 @default.
• W3096526866 cites W4240703051 @default.
• W3096526866 doi "https://doi.org/10.1016/j.clcc.2020.10.005" @default.
• W3096526866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33243618" @default.
• W3096526866 hasPublicationYear "2021" @default.
• W3096526866 type Work @default.
• W3096526866 sameAs 3096526866 @default.
• W3096526866 citedByCount "5" @default.
• W3096526866 countsByYear W30965268662021 @default.
• W3096526866 countsByYear W30965268662022 @default.
• W3096526866 crossrefType "journal-article" @default.
• W3096526866 hasAuthorship W3096526866A5003117278 @default.
• W3096526866 hasAuthorship W3096526866A5021967161 @default.
• W3096526866 hasAuthorship W3096526866A5024180743 @default.
• W3096526866 hasAuthorship W3096526866A5052808201 @default.
• W3096526866 hasAuthorship W3096526866A5074210261 @default.
• W3096526866 hasBestOaLocation W30965268661 @default.
• W3096526866 hasConcept C111113717 @default.
• W3096526866 hasConcept C112705442 @default.
• W3096526866 hasConcept C126322002 @default.
• W3096526866 hasConcept C177713679 @default.
• W3096526866 hasConcept C2776694085 @default.
• W3096526866 hasConcept C2777802072 @default.
• W3096526866 hasConcept C535046627 @default.
• W3096526866 hasConcept C59491497 @default.
• W3096526866 hasConcept C71924100 @default.
• W3096526866 hasConcept C98274493 @default.
• W3096526866 hasConceptScore W3096526866C111113717 @default.
• W3096526866 hasConceptScore W3096526866C112705442 @default.
• W3096526866 hasConceptScore W3096526866C126322002 @default.
• W3096526866 hasConceptScore W3096526866C177713679 @default.
• W3096526866 hasConceptScore W3096526866C2776694085 @default.
• W3096526866 hasConceptScore W3096526866C2777802072 @default.
• W3096526866 hasConceptScore W3096526866C535046627 @default.
• W3096526866 hasConceptScore W3096526866C59491497 @default.
• W3096526866 hasConceptScore W3096526866C71924100 @default.
• W3096526866 hasConceptScore W3096526866C98274493 @default.
• W3096526866 hasFunder F4320307105 @default.
• W3096526866 hasFunder F4320307771 @default.
• W3096526866 hasFunder F4320307779 @default.
• W3096526866 hasFunder F4320329930 @default.
• W3096526866 hasIssue "1" @default.
• W3096526866 hasLocation W30965268661 @default.
• W3096526866 hasLocation W30965268662 @default.
• W3096526866 hasOpenAccess W3096526866 @default.
• W3096526866 hasPrimaryLocation W30965268661 @default.
• W3096526866 hasRelatedWork W1993762334 @default.
• W3096526866 hasRelatedWork W2254638634 @default.
• W3096526866 hasRelatedWork W2369345461 @default.

• next